Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amenorrhea | 8 | 2017 | 16 | 0.850 |
Why?
|
| Hypothalamic Diseases | 6 | 2017 | 6 | 0.720 |
Why?
|
| Polycystic Ovary Syndrome | 5 | 2017 | 13 | 0.540 |
Why?
|
| Estradiol | 10 | 2017 | 176 | 0.480 |
Why?
|
| Hydrocortisone | 10 | 2017 | 291 | 0.460 |
Why?
|
| Anovulation | 3 | 2005 | 6 | 0.410 |
Why?
|
| Testosterone | 4 | 2017 | 96 | 0.350 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2009 | 38 | 0.330 |
Why?
|
| Gonadal Steroid Hormones | 4 | 2011 | 52 | 0.330 |
Why?
|
| Postmenopause | 1 | 2009 | 92 | 0.330 |
Why?
|
| Estrogens | 1 | 2009 | 173 | 0.310 |
Why?
|
| Dementia | 1 | 2009 | 158 | 0.290 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 317 | 0.270 |
Why?
|
| Ovary | 3 | 2005 | 99 | 0.260 |
Why?
|
| Brain Injuries | 3 | 2013 | 268 | 0.250 |
Why?
|
| Stress, Psychological | 3 | 2017 | 824 | 0.240 |
Why?
|
| Hypothalamus | 3 | 2011 | 78 | 0.240 |
Why?
|
| Brain | 3 | 2011 | 2176 | 0.230 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2011 | 150 | 0.230 |
Why?
|
| Female | 37 | 2017 | 38021 | 0.220 |
Why?
|
| Luteinizing Hormone | 7 | 2011 | 31 | 0.220 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 286 | 0.220 |
Why?
|
| Puberty, Precocious | 2 | 2011 | 2 | 0.180 |
Why?
|
| Adrenarche | 2 | 2011 | 2 | 0.180 |
Why?
|
| Aromatase Inhibitors | 2 | 2011 | 17 | 0.180 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 2 | 2011 | 11 | 0.180 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 1997 | 32 | 0.170 |
Why?
|
| Adult | 24 | 2017 | 21379 | 0.170 |
Why?
|
| Humans | 40 | 2017 | 68549 | 0.160 |
Why?
|
| Cognition Disorders | 2 | 2012 | 342 | 0.160 |
Why?
|
| Pregnancy Outcome | 2 | 2016 | 157 | 0.160 |
Why?
|
| Progesterone | 5 | 2007 | 115 | 0.160 |
Why?
|
| Pituitary-Adrenal System | 2 | 2011 | 138 | 0.160 |
Why?
|
| Maternal Mortality | 1 | 2017 | 16 | 0.150 |
Why?
|
| Maternal Health Services | 1 | 2017 | 22 | 0.150 |
Why?
|
| Cognition | 2 | 2012 | 512 | 0.140 |
Why?
|
| Circadian Rhythm | 4 | 2007 | 218 | 0.140 |
Why?
|
| Case-Control Studies | 7 | 2017 | 1549 | 0.140 |
Why?
|
| Aromatase | 2 | 2013 | 8 | 0.140 |
Why?
|
| Anal Canal | 1 | 2016 | 20 | 0.140 |
Why?
|
| Genetic Techniques | 1 | 2016 | 32 | 0.130 |
Why?
|
| Delivery, Obstetric | 1 | 2016 | 58 | 0.130 |
Why?
|
| Pulsatile Flow | 3 | 2011 | 20 | 0.130 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2010 | 79 | 0.130 |
Why?
|
| Hysterectomy | 1 | 2015 | 64 | 0.130 |
Why?
|
| Uterine Prolapse | 1 | 2015 | 29 | 0.130 |
Why?
|
| Prenatal Diagnosis | 1 | 2016 | 73 | 0.130 |
Why?
|
| Cause of Death | 1 | 2016 | 241 | 0.130 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 208 | 0.130 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2015 | 6 | 0.130 |
Why?
|
| Fetus | 1 | 2016 | 157 | 0.130 |
Why?
|
| Ascitic Fluid | 1 | 2015 | 22 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 136 | 0.130 |
Why?
|
| Endometriosis | 1 | 2015 | 56 | 0.130 |
Why?
|
| Up-Regulation | 1 | 2017 | 682 | 0.120 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2015 | 53 | 0.120 |
Why?
|
| Stress, Physiological | 4 | 2012 | 215 | 0.120 |
Why?
|
| Aging | 2 | 2011 | 911 | 0.120 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 92 | 0.120 |
Why?
|
| Fasting | 2 | 2005 | 75 | 0.110 |
Why?
|
| Pregnancy | 5 | 2017 | 2334 | 0.110 |
Why?
|
| Neurosecretory Systems | 1 | 2013 | 21 | 0.110 |
Why?
|
| DNA | 1 | 2016 | 597 | 0.110 |
Why?
|
| Leptin | 3 | 2013 | 80 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2000 | 938 | 0.110 |
Why?
|
| Hypogonadism | 1 | 2012 | 9 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2013 | 220 | 0.100 |
Why?
|
| Obesity | 2 | 2011 | 1074 | 0.100 |
Why?
|
| Georgia | 3 | 2017 | 161 | 0.100 |
Why?
|
| Exercise | 1 | 2017 | 658 | 0.100 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2011 | 10 | 0.100 |
Why?
|
| Age Factors | 3 | 2015 | 1860 | 0.100 |
Why?
|
| Drug Administration Schedule | 2 | 2011 | 567 | 0.100 |
Why?
|
| Cytoprotection | 1 | 2011 | 39 | 0.100 |
Why?
|
| Pituitary Gland | 1 | 2011 | 29 | 0.100 |
Why?
|
| Developmental Disabilities | 1 | 2011 | 119 | 0.090 |
Why?
|
| Ghrelin | 1 | 2010 | 8 | 0.090 |
Why?
|
| Menstrual Cycle | 2 | 2007 | 64 | 0.090 |
Why?
|
| Energy Intake | 1 | 2010 | 123 | 0.090 |
Why?
|
| Cross-Sectional Studies | 5 | 2017 | 2265 | 0.090 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2009 | 3 | 0.090 |
Why?
|
| Follicle Stimulating Hormone | 5 | 2011 | 29 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 517 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2011 | 295 | 0.080 |
Why?
|
| Androgens | 1 | 2008 | 41 | 0.080 |
Why?
|
| Models, Animal | 1 | 2009 | 252 | 0.080 |
Why?
|
| Hyperandrogenism | 1 | 1997 | 2 | 0.080 |
Why?
|
| Biomarkers | 4 | 2017 | 1593 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2010 | 483 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 1999 | 191 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 201 | 0.070 |
Why?
|
| Depression, Postpartum | 1 | 2007 | 9 | 0.070 |
Why?
|
| Biopsy | 1 | 1999 | 539 | 0.070 |
Why?
|
| HIV Infections | 1 | 2015 | 775 | 0.070 |
Why?
|
| Body Mass Index | 5 | 2011 | 866 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 2007 | 173 | 0.070 |
Why?
|
| Limbic System | 1 | 2007 | 106 | 0.070 |
Why?
|
| Knee Joint | 1 | 2007 | 115 | 0.070 |
Why?
|
| Lipids | 1 | 1998 | 298 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 160 | 0.070 |
Why?
|
| Saliva | 1 | 2007 | 142 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 438 | 0.070 |
Why?
|
| Coronary Disease | 1 | 1998 | 358 | 0.070 |
Why?
|
| Young Adult | 5 | 2017 | 5710 | 0.070 |
Why?
|
| Pennsylvania | 2 | 2017 | 46 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2016 | 621 | 0.070 |
Why?
|
| Risk Factors | 4 | 2015 | 5720 | 0.060 |
Why?
|
| Hypothyroidism | 1 | 2005 | 24 | 0.060 |
Why?
|
| Clinical Competence | 1 | 1999 | 657 | 0.060 |
Why?
|
| Middle Aged | 8 | 2016 | 21119 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2005 | 222 | 0.060 |
Why?
|
| Androstenedione | 2 | 2017 | 7 | 0.060 |
Why?
|
| Adolescent | 6 | 2016 | 8904 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2009 | 2004 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2013 | 7028 | 0.050 |
Why?
|
| Melatonin | 1 | 2001 | 39 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2000 | 40 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2001 | 102 | 0.050 |
Why?
|
| Receptors, Serotonin | 1 | 2000 | 74 | 0.050 |
Why?
|
| Thyrotropin | 2 | 2013 | 49 | 0.050 |
Why?
|
| Reference Values | 3 | 2000 | 579 | 0.040 |
Why?
|
| Ovulation | 3 | 2001 | 10 | 0.040 |
Why?
|
| Radioimmunoassay | 2 | 2011 | 164 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2000 | 161 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 1533 | 0.040 |
Why?
|
| Cholesterol | 1 | 2000 | 331 | 0.040 |
Why?
|
| Interleukin-1 | 2 | 1988 | 86 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2000 | 453 | 0.040 |
Why?
|
| Prolactin | 2 | 2007 | 61 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 2356 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2017 | 86 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2017 | 169 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 1851 | 0.040 |
Why?
|
| Exercise Test | 1 | 2017 | 242 | 0.030 |
Why?
|
| Protein Binding | 2 | 2011 | 1027 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2016 | 43 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2016 | 46 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 307 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 568 | 0.030 |
Why?
|
| Mortality | 1 | 2016 | 162 | 0.030 |
Why?
|
| Child | 3 | 2011 | 6401 | 0.030 |
Why?
|
| Urban Population | 1 | 2016 | 254 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 631 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2000 | 1449 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2015 | 117 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2017 | 332 | 0.030 |
Why?
|
| Luteal Phase | 2 | 2005 | 25 | 0.030 |
Why?
|
| Affect | 2 | 2008 | 218 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2016 | 7268 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 447 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2013 | 22 | 0.030 |
Why?
|
| Aged | 3 | 2015 | 14842 | 0.030 |
Why?
|
| Premature Birth | 1 | 2015 | 150 | 0.030 |
Why?
|
| Rural Population | 1 | 2016 | 397 | 0.030 |
Why?
|
| Thyroxine | 1 | 2013 | 62 | 0.030 |
Why?
|
| Male | 5 | 2013 | 37283 | 0.030 |
Why?
|
| Glasgow Outcome Scale | 1 | 2012 | 15 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 4655 | 0.030 |
Why?
|
| Menarche | 1 | 2011 | 18 | 0.030 |
Why?
|
| Verbal Learning | 1 | 2011 | 29 | 0.030 |
Why?
|
| Synaptic Potentials | 1 | 2011 | 8 | 0.030 |
Why?
|
| Intelligence | 1 | 2011 | 45 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2077 | 0.030 |
Why?
|
| Anthropometry | 1 | 2011 | 64 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2011 | 83 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 166 | 0.020 |
Why?
|
| Arousal | 1 | 2011 | 168 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1419 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 238 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 281 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 88 | 0.020 |
Why?
|
| Body Composition | 1 | 2011 | 119 | 0.020 |
Why?
|
| Nitriles | 1 | 2011 | 68 | 0.020 |
Why?
|
| Triazoles | 1 | 2011 | 43 | 0.020 |
Why?
|
| Social Dominance | 1 | 2010 | 4 | 0.020 |
Why?
|
| Breast | 1 | 2011 | 137 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2010 | 49 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1040 | 0.020 |
Why?
|
| Food Preferences | 1 | 2010 | 46 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2010 | 76 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 627 | 0.020 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2010 | 24 | 0.020 |
Why?
|
| Aggression | 1 | 2010 | 98 | 0.020 |
Why?
|
| Overweight | 1 | 2011 | 186 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 658 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 506 | 0.020 |
Why?
|
| Social Behavior | 1 | 2010 | 164 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1999 | 193 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1046 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 274 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 224 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 1998 | 25 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 955 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1988 | 72 | 0.020 |
Why?
|
| Body Height | 1 | 2008 | 67 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1054 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1997 | 28 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1265 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 2007 | 34 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2010 | 470 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 306 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 1998 | 161 | 0.020 |
Why?
|
| Serotonin Antagonists | 1 | 2007 | 31 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1997 | 89 | 0.020 |
Why?
|
| Reproduction | 1 | 2007 | 48 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 1999 | 799 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2007 | 62 | 0.020 |
Why?
|
| Motor Skills | 1 | 2007 | 88 | 0.020 |
Why?
|
| Linear Models | 1 | 1998 | 521 | 0.020 |
Why?
|
| Survival Rate | 1 | 1999 | 1055 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2007 | 139 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2006 | 17 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 2093 | 0.020 |
Why?
|
| Body Weight | 1 | 2008 | 554 | 0.020 |
Why?
|
| Binding, Competitive | 2 | 2000 | 165 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2007 | 368 | 0.020 |
Why?
|
| Piperazines | 1 | 2007 | 206 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2007 | 159 | 0.020 |
Why?
|
| Pyridines | 1 | 2007 | 261 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 1753 | 0.020 |
Why?
|
| Anxiety | 1 | 2008 | 422 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2007 | 782 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2012 | 3703 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 2798 | 0.010 |
Why?
|
| United States | 1 | 2015 | 7338 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2006 | 597 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 4843 | 0.010 |
Why?
|
| Thyronines | 1 | 2001 | 1 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2001 | 6 | 0.010 |
Why?
|
| Follicular Phase | 1 | 2001 | 15 | 0.010 |
Why?
|
| Attitude | 1 | 2001 | 121 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2001 | 219 | 0.010 |
Why?
|
| Feeding and Eating Disorders | 1 | 2001 | 106 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2001 | 447 | 0.010 |
Why?
|
| Animals | 2 | 2010 | 20880 | 0.010 |
Why?
|
| Depression | 1 | 2001 | 942 | 0.010 |
Why?
|
| Immunochemistry | 1 | 1988 | 17 | 0.010 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1988 | 18 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1988 | 114 | 0.000 |
Why?
|
| Cell Division | 1 | 1988 | 541 | 0.000 |
Why?
|
| Cell Adhesion | 1 | 1988 | 324 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1988 | 489 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1988 | 852 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1988 | 299 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1988 | 689 | 0.000 |
Why?
|
| Cell Line | 1 | 1988 | 1752 | 0.000 |
Why?
|